Harold Marcotte, Ph. D.
Dr Harold Marcotte is an associate Professor within the Division of Clinical Immunology and Transfusion Medicine, Department of Laboratory Medicine in Karolinska Institutet. He obtained a BSc (1990) and a MSc in Microbiology (1992) as well as a PhD in Microbiology and Immunology (1997) at Université Laval, Canada. He performed postdoctoral studies at the Department of Pathology, University of Cambridge, UK (1997-1998) and the Department of Molecular biology, University of Siena, Italy (1998-2000) working on mucosal vaccines.
In 2000, he joined the Division of Clinical Immunology at Karolinska Institutet as a postdoctoral researcher working in the field of antibody therapy, probiotics and microbial engineering. He became Senior researcher in the division of Clinical immunology in 2007 and docent in 2018. He has published a total of 50 publications in the field of antibody development, antibody engineering, and antibody delivery system for therapy against Clostridium difficile, Helicobacter pylori, HIV, norovirus, and coronavirus. Dr Marcotte has managed two EU projects in the past and he is the current scientific manager of the ATAC project aiming to establish a passive immunotherapy against COVID-19.